Rho kinase (ROCK) inhibitors in the management of corneal endothelial disease.

Syed ZA, Rapuano CJ. Rho kinase (ROCK) inhibitors in the management of corneal endothelial disease. Curr Opin Ophthalmol. 2021 May 01; 32(3):268-274.

View in: PubMed

subject areas

Benzoates
beta-Alanine
Fuchs' Endothelial Dystrophy
Humans
Isoquinolines
Protein Kinase Inhibitors
rho-Associated Kinases
Sulfonamides

authors with profiles

Zeba Syed
Christopher Rapuano

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement